Detalhe da pesquisa
1.
Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial.
Lancet
; 402(10397): 185-195, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290461
2.
Physiotherapy for continence and muscle function in prostatectomy: a randomised controlled trial.
BJU Int
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658057
3.
The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin therapy.
Jpn J Clin Oncol
; 54(2): 192-200, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37974430
4.
Longitudinal mortality risks and kidney functional outcomes in Japanese living kidney donors.
Int J Urol
; 31(5): 519-524, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240161
5.
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy.
Int J Urol
; 31(5): 526-533, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240169
6.
Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers.
Cancer Sci
; 114(8): 3385-3395, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208840
7.
Impact of postoperative complications on long-term survival in bladder cancer patients.
Jpn J Clin Oncol
; 53(10): 966-976, 2023 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461191
8.
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma.
Int J Clin Oncol
; 28(3): 416-426, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36595123
9.
Stroma biglycan expression can be a prognostic factor in prostate cancers.
Int J Urol
; 30(2): 147-154, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305810
10.
Clinical Practice Guidelines for tuberous sclerosis complex-associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update.
Int J Urol
; 30(10): 808-817, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37278492
11.
Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study.
Int J Urol
; 30(11): 977-984, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434386
12.
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
Int J Urol
; 30(9): 762-771, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248753
13.
Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study.
Int J Urol
; 30(11): 1044-1050, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37522577
14.
[A Case of Testicular Cancer with Solitary Iliac Bone Metastasis].
Hinyokika Kiyo
; 69(9): 259-264, 2023 Sep.
Artigo
em Japonês
| MEDLINE | ID: mdl-37794677
15.
In-Operando Lithium-Ion Transport Tracking in an All-Solid-State Battery.
Small
; 18(46): e2204455, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180412
16.
IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation.
BMC Cancer
; 22(1): 1292, 2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36494792
17.
Overview of clinical management for older patients with renal cell carcinoma.
Jpn J Clin Oncol
; 52(7): 665-681, 2022 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35397166
18.
Objective evaluation of laparoscopic surgical skills in wet lab training based on motion analysis and machine learning.
Langenbecks Arch Surg
; 407(5): 2123-2132, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35394212
19.
Outcomes of bacillus Calmette-Guérin therapy without a maintenance schedule for high-risk non-muscle-invasive bladder cancer in the second transurethral resection era.
Int J Urol
; 29(3): 251-258, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894009
20.
Late recurrence in patients with non-muscle-invasive bladder cancer after 5-year cancer-free periods.
Int J Urol
; 29(10): 1140-1146, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35598096